Inhibition of Drp1-dependent mitochondrial fission by natural compounds as a therapeutic strategy for organ injuries

Pharmacol Res. 2023 Feb:188:106672. doi: 10.1016/j.phrs.2023.106672. Epub 2023 Jan 20.

Abstract

Mitochondria are morphologically dynamic organelles frequently undergoing fission and fusion processes that regulate mitochondrial integrity and bioenergetics. These processes are considered critical for cell survival. The mitochondrial fission process regulates mitochondrial biogenesis and mitophagy. It is associated with apoptosis, while mitochondrial fusion controls the accurate distribution of mitochondrial DNA and metabolic substances across the mitochondria. Excessive mitochondrial fission results in mitochondrial structural changes, dysfunction, and cell damage. Accumulating evidence demonstrates that mitochondrial dynamics affect neurodegenerative and cardiovascular diseases along with several other diseases. Biological molecules regulating the process of mitochondrial fission are potential targets for developing therapeutic agents. Many natural products target the dynamin-related protein 1 (Drp1)-dependent mitochondrial fission pathway, and their inhibitory effects ameliorate mitochondrial fragmentation. In this article, we reviewed the research literature that describes Drp1-dependent inhibition as a mechanism for the protective effects of natural compounds.

Keywords: Apoptosis; Dynamin-related protein 1; Fission inhibitors; Free radical production; Herbal medicine; Mitochondrial fission; Mitochondrial fusion; Natural compound.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases* / metabolism
  • DNA, Mitochondrial / metabolism
  • Dynamins / metabolism
  • Humans
  • Mitochondria / metabolism
  • Mitochondrial Dynamics* / physiology
  • Mitochondrial Proteins / metabolism

Substances

  • Dynamins
  • DNA, Mitochondrial
  • Mitochondrial Proteins